pembrolizumab,int-2306
intensity therapeutics,merck
['pembro', 'ease,(-please),(-disease),(-incrrease),(-decrease)', 'intensitythera']
#intensitytherapeutics #int2306 demonstrates increased survival as either #monotherapy or in combination with #pembrolizumab in patients with #relapsed #refractory #metastatic #solidtumorcancers #sitc22 